Detalles de la búsqueda
1.
Dose escalation of subcutaneous epcoritamab in patients with relapsed or refractory B-cell non-Hodgkin lymphoma: an open-label, phase 1/2 study.
Lancet
; 398(10306): 1157-1169, 2021 09 25.
Artículo
en Inglés
| MEDLINE | ID: mdl-34508654
2.
Venetoclax plus R- or G-CHOP in non-Hodgkin lymphoma: results from the CAVALLI phase 1b trial.
Blood
; 133(18): 1964-1976, 2019 05 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-30850381
3.
Treatment of patients with MYC rearrangement positive large B-cell lymphoma with R-CHOP plus lenalidomide: results of a multicenter HOVON phase II trial.
Haematologica
; 105(12): 2805-2812, 2020 12 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-33256379
4.
Survival disparities between children and adolescents and young adults for the major subtypes of non-Hodgkin lymphoma in the Netherlands: a large population-based study.
Haematologica
; 109(3): 936-941, 2024 Mar 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-37646666
5.
CD20 and CD37 antibodies synergize to activate complement by Fc-mediated clustering.
Haematologica
; 104(9): 1841-1852, 2019 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-30792198
6.
Feasibility and efficacy of addition of individualized-dose lenalidomide to chlorambucil and rituximab as first-line treatment in elderly and FCR-unfit patients with advanced chronic lymphocytic leukemia.
Haematologica
; 104(1): 147-154, 2019 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-30115656
7.
Trends in incidence, treatment and survival of aggressive B-cell lymphoma in the Netherlands 1989-2010.
Haematologica
; 100(4): 525-33, 2015 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-25512643
8.
Turning the tide in aggressive lymphoma: liquid biopsy for risk-adapted treatment strategies.
Trends Mol Med
; 2024 May 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-38692937
9.
Distinct peripheral T-cell and NK-cell profiles in HGBL-MYC/BCL2 vs patients with DLBCL NOS.
Blood Adv
; 8(5): 1094-1104, 2024 Mar 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-38191686
10.
Chemotherapy resistant Burkitt lymphoma: Possible novel therapies including CAR-T cell infusion.
Clin Case Rep
; 11(6): e7361, 2023 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-37260617
11.
A population-based study of transformed marginal zone lymphoma: identifying outcome-related characteristics.
Blood Cancer J
; 13(1): 130, 2023 09 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-37658062
12.
Baseline radiomics features and MYC rearrangement status predict progression in aggressive B-cell lymphoma.
Blood Adv
; 7(2): 214-223, 2023 01 24.
Artículo
en Inglés
| MEDLINE | ID: mdl-36306337
13.
A non-randomized risk-adjusted comparison of lenalidomide + R-CHOP versus R-CHOP for MYC-rearranged DLBCL patients.
Blood Cancer J
; 13(1): 85, 2023 05 22.
Artículo
en Inglés
| MEDLINE | ID: mdl-37217463
14.
Genomic profiling of post-transplant lymphoproliferative disorders using cell-free DNA.
J Hematol Oncol
; 16(1): 104, 2023 09 14.
Artículo
en Inglés
| MEDLINE | ID: mdl-37705050
15.
The Dutch CAR-T Tumorboard Experience: Population-Based Real-World Data on Patients with Relapsed or Refractory Large B-Cell Lymphoma Referred for CD19-Directed CAR T-Cell Therapy in The Netherlands.
Cancers (Basel)
; 15(17)2023 Aug 30.
Artículo
en Inglés
| MEDLINE | ID: mdl-37686611
16.
R-CODOX-M/R-IVAC versus DA-EPOCH-R in patients with newly diagnosed Burkitt lymphoma (HOVON/SAKK): final results of a multicentre, phase 3, open-label, randomised trial.
Lancet Haematol
; 10(12): e966-e975, 2023 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-37922925
17.
Class II-associated invariant chain peptide expression represents a novel parameter for flow cytometric detection of acute promyelocytic leukemia.
Am J Pathol
; 179(5): 2157-61, 2011 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-21907692
18.
Aberrant immunophenotype of blasts in myelodysplastic syndromes is a clinically relevant biomarker in predicting response to growth factor treatment.
Blood
; 115(9): 1779-84, 2010 Mar 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-20038788
19.
The path towards consensus genome classification of diffuse large B-cell lymphoma for use in clinical practice.
Front Oncol
; 12: 970063, 2022.
Artículo
en Inglés
| MEDLINE | ID: mdl-36387143
20.
Time trends in primary therapy and relative survival of diffuse large B-cell lymphoma by stage: a nationwide, population-based study in the Netherlands, 1989-2018.
Blood Cancer J
; 12(3): 38, 2022 03 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-35264598